Stock IOVA IOVANCE BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Iovance Biotherapeutics, Inc.

Equities

IOVA

US4622601007

Real-time Estimate Cboe BZX
Other stock markets
 20:49:17 02/05/2024 BST 		5-day change 1st Jan Change
12.82 USD +2.52% Intraday chart for Iovance Biotherapeutics, Inc. +11.18% +57.81%
03-29 General (Ret.) Merrill A. McPeak, Member of the Board of Directors of Iovance Biotherapeutics, Inc. Retires and Not Stands for Re-Election CI
03-14 Piper Sandler Adjusts Iovance Biotherapeutics Price Target to $19 From $18, Maintains Overweight Rating MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. IOVA Stock
  4. Revisions Iovance Biotherapeutics, Inc.